LifeSignals, a pioneering company in patient monitoring technology, has taken a significant step forward with its latest achievement: the EU MDR Certification for the UbiqVue 2A Multiparameter System. This certification underscores the system’s capability to revolutionize patient care both inside and outside of hospital settings.
The UbiqVue 2A system is designed for continuous, near real-time monitoring of patient health via an innovative cloud-based platform. This system eliminates the need for outdated, sporadic manual checks, offering a seamless solution to track a range of patient vitals continuously. Healthcare practitioners can now access a web-based display that streams multiple physiological data points, complete with visual alarms and alert notifications, enhancing the efficiency and responsiveness of patient care.
The heart of this advanced system is the UbiqVue 2A Biosensor. This single-use device collects essential physiological data right from the patient’s chest. It offers comprehensive monitoring of twelve parameters, which includes a 2-channel ECG, pulse rate, and body temperature, among others. Thanks to a patented white light spectral SpO2 technology from BioIntelliSense, Inc., the chest-worn Biosensor ensures accurate and continuous monitoring of blood oxygen levels across all skin tones.
Surendar Magar, Co-founder and CEO of LifeSignals, highlights the impact of achieving the Class IIb EU MDR Certification. “This certification typically applies to devices used for continuous surveillance in demanding care environments like anesthesia and intensive care,” he notes. “Achieving this milestone demonstrates our commitment to delivering a patient monitoring experience comparable to bedside monitors, via an affordable, single-use Biosensor.”
LifeSignals aims to reshape healthcare delivery by developing scalable solutions for both individual and population health. This goal is supported by partnerships with original equipment manufacturers, service providers, and distributors worldwide, ensuring broad access to their innovative technology.
As the UbiqVue system rolls out, it’s poised to significantly impact patient care strategies on a global scale, underscoring LifeSignals’ dedication to wireless healthcare advancements. This initiative aligns with their mission to provide effective, economical monitoring solutions driven by cutting-edge technology.
The introduction of the UbiqVue 2A Multiparameter System stands as a testament to LifeSignals’ visionary approach to the future of healthcare, offering a promising tool for both medical professionals and patients alike in maintaining and improving health outcomes globally.
